Alzheimer’s proteins beaten back by sleeping pill in small study
The pills showed promise in combating the substances that lead to the harmful tangles and plaques in the brain that contribute to the disease.
Science & academia
This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.
New nuclear medicine therapy cures human non-hodgkin lymphoma in preclinical model
A single dose of this radioimmunotherapy was found to eliminate tumor cells and extend the life of mice injected with cancerous cells for more than 221 days (the trial endpoint), compared to just 19 days in untreated control mice.
Experimental pill achieves complete cancer remission in 18 people with aggressive leukemia
The new drug, called revumenib, has completely eliminated cancer in a third of the participants in a long-awaited clinical study from the University of Texas.
Breakthrough drug works against all the main types of primary bone cancer
Bone cancer research has taken a meaningful step forward, with scientists identifying a single drug candidate that shows activity across all the major types of primary bone cancer — a group of diseases that have long resisted a unified treatment approach. Because these cancers disproportionately affect children and young people, the stakes are especially high. The compound appears to target something the different subtypes share biologically, which could open new research directions well beyond this one discovery. For pediatric cancer medicine, that kind of insight builds the foundation treatments are eventually made from.\n\nWord count: 88
Researchers cure toddler of deadly metachromatic leukodystrophy (MLD) for first time in history
Gene therapy has cured 19-month-old Teddi Shaw of metachromatic leukodystrophy, making her the first NHS patient treated for this rare, fatal nervous system disease. After a single infusion of Libmeldy at Royal Manchester Children’s Hospital, she’s now running around, chattering away, and showing no signs of the illness that typically kills children before age eight. The treatment works by correcting a faulty gene in the child’s own stem cells, eliminating the disease at its root rather than managing it. Her family’s joy is tempered by grief — Teddi’s older sister was diagnosed too late for the therapy to help, fueling calls for newborn screening. It’s a glimpse of medicine’s next era: one-time cures for inherited conditions, if access and early detection can keep pace.
World’s largest four day work week trial deemed a success
An incredible 92 percent of companies said they would continue to have employees work four days.
26 Australian species no longer need threatened listing
Australian wildlife is staging a quiet comeback, with 26 threatened animals — including the greater bilby, humpback whale, and sooty albatross — now recovered enough to fall outside the country’s threatened-species criteria. A new study in Biological Conservation, drawing on more than two decades of data, credits much of the progress to fencing off predators like cats and foxes, relocating vulnerable populations to island sanctuaries, and steady habitat care. Researchers call these “partial successes” — many species still occupy just slivers of their historic range — but the pattern is unmistakable: when people show up year after year, decline can be reversed. In a country that has lost more mammals to extinction than any other, it’s a hopeful blueprint for conservation everywhere.
Brain circuit breakthrough paves way for opioid addiction treatments
Scientists have discovered a specific brain circuit that drives the emotional crash—anxiety, depression, craving—keeping people trapped in the fentanyl cycle even after they’ve stopped using. By identifying this discrete target, researchers now have a concrete mechanism to aim at rather than the broad-brush approach of current treatments. The finding matters because it fills a gap addiction medicine has long faced: understanding exactly how fentanyl rewires the brain. This precision opens a path toward tailored therapies that could ease withdrawal’s emotional weight and improve the odds of lasting recovery.\n\n**Word count: 99**
Researchers can now pull green hydrogen directly from seawater
University of Adelaide researchers claim to have made clean hydrogen fuel from seawater without pre-treatment. Their findings could eventually provide cheaper green energy production from a near-limitless source to coastal areas.
First vaccine to target deadly fungal infections passes preclinical tests
Fungal infections kill an estimated 1.6 million people every year, yet until now no vaccine has ever existed for any of the major culprits. Researchers at the University of Georgia have developed a single shot that trains the immune system to recognize all three deadliest fungal genera simultaneously — a feat never before demonstrated in peer-reviewed research. Crucially, it reduced illness and death in immunocompromised animals, the very people most at risk. For a disease category the WHO only recently recognized as a global emergency, this candidate offers the first real hope of prevention.\n\n*(Word count: 88)*